Alterations of cellular bioenergetics in pulmonary artery endothelial cells
- PMID: 17227868
- PMCID: PMC1783136
- DOI: 10.1073/pnas.0605080104
Alterations of cellular bioenergetics in pulmonary artery endothelial cells
Abstract
Idiopathic pulmonary arterial hypertension (IPAH) is pathogenetically related to low levels of the vasodilator nitric oxide (NO). Because NO regulates cellular respiration and mitochondrial biogenesis, we hypothesized that abnormalities of bioenergetics may be present in IPAH. Evaluation of pulmonary artery endothelial cells from IPAH and control lungs in vitro revealed that oxygen consumption of IPAH cells was decreased, especially in state 3 respiration with substrates glutamate-malate or succinate, and this decrease paralleled reduction in Complex IV activity and IPAH cellular NO synthesis. IPAH pulmonary artery endothelial cells had decreased mitochondrial dehydrogenase activity and lowered mitochondrial numbers per cell and mitochondrial DNA content, all of which increased after exposure to NO donors. Although IPAH/pulmonary artery endothelial cells' ATP content was similar to control under normoxia, cellular ATP did not change significantly in IPAH cells under hypoxia, whereas ATP decreased 35% in control cells, identifying a greater dependence on cellular respiration for energy in control cells. Evidence that glucose metabolism was subserving the primary role for energy requirements of IPAH cells was provided by the approximately 3-fold greater glycolytic rate of IPAH cells. Positron emission tomography scan with [18F]fluoro-deoxy-D-glucose performed on IPAH patients and healthy controls revealed significantly higher uptake in IPAH lungs as compared with controls, confirming that the glycolytic rate was increased in vivo. Thus, there are substantial changes in bioenergetics of IPAH endothelial cells, which may have consequences for pulmonary hypertensive responses and potentially in development of novel imaging modalities for diagnosis and evaluation of treatment.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension.Respir Med. 2008 Jul;102(7):1073-9. doi: 10.1016/j.rmed.2007.12.030. Epub 2008 Apr 3. Respir Med. 2008. PMID: 18394873
-
Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.Arthritis Rheum. 2008 Apr;58(4):1156-64. doi: 10.1002/art.23405. Arthritis Rheum. 2008. PMID: 18383374
-
Altered nano/micro-order elasticity of pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.Int J Cardiol. 2010 Apr 1;140(1):102-7. doi: 10.1016/j.ijcard.2008.11.022. Epub 2008 Dec 14. Int J Cardiol. 2010. PMID: 19073348
-
Alterations in bioenergetics due to changes in mitochondrial DNA copy number.Methods. 2010 Aug;51(4):452-7. doi: 10.1016/j.ymeth.2010.03.006. Epub 2010 Mar 25. Methods. 2010. PMID: 20347038 Review.
-
Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension.Compr Physiol. 2011 Jan;1(1):357-72. doi: 10.1002/cphy.c090005. Compr Physiol. 2011. PMID: 23737177 Free PMC article. Review.
Cited by
-
Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.Ann Am Thorac Soc. 2013 Feb;10(1):1-9. doi: 10.1513/AnnalsATS.201206-029OC. Ann Am Thorac Soc. 2013. PMID: 23509326 Free PMC article.
-
Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension.EMBO Mol Med. 2015 Jun;7(6):695-713. doi: 10.15252/emmm.201404511. EMBO Mol Med. 2015. PMID: 25825391 Free PMC article.
-
Mast cell number, phenotype, and function in human pulmonary arterial hypertension.Pulm Circ. 2012 Apr-Jun;2(2):220-8. doi: 10.4103/2045-8932.97609. Pulm Circ. 2012. PMID: 22837863 Free PMC article.
-
The metabolic engine of endothelial cells.Nat Metab. 2019 Oct;1(10):937-946. doi: 10.1038/s42255-019-0117-9. Epub 2019 Sep 30. Nat Metab. 2019. PMID: 32694836 Review.
-
Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension.Sci Rep. 2019 Dec 9;9(1):18623. doi: 10.1038/s41598-019-55053-6. Sci Rep. 2019. PMID: 31819116 Free PMC article.
References
-
- Jeffery TK, Morrell NW. Prog Cardiovasc Dis. 2002;45:173–202. - PubMed
-
- Archer S, Rich S. Circulation. 2000;102:2781–2791. - PubMed
-
- Kaneko FT, Arroliga AC, Dweik RA, Comhair SA, Laskowski D, Oppedisano R, Thomassen MJ, Erzurum SC. Am J Respir Crit Care Med. 1998;158:917–923. - PubMed
-
- Azeka E, Costa Auler JO, Jr, Kajita L, Alliman AC, Franchini Ramires JA, Ebaid M. Pediatr Cardiol. 2002;23:20–26. - PubMed
-
- Cooke JP, Dzau VJ. Circulation. 1997;96:379–382. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources